Invesco Ltd (IVZ) Pops 3.34% for January 22

Equities Staff  |

One of the S&P 500’s big winners for Friday January 22 was Invesco Ltd (IVZ) as the company’s stock climbed 3.34% to $29.38 on volume of 3.22 million shares.

The stock opened at $28.96 and saw an intraday low of $28.89 and an intraday high of $29.53. All told, the day saw a per-share gain of $0.95. The stock’s average daily volume of 3.73 million and 423.86 million shares outstanding. Invesco Ltd now has a 50-day SMA is $32.06 and 200-day SMA is $35.25, and it has a 52-week high of $42.05 and a 52-week low of $27.36.

Invesco Ltd is an investment management company operating in more than 20 countries. It provides retail and institutional clients with an array of investment management capabilities. It has presence in the institutional and retail markets.

Based out of Atlanta, GA, Invesco Ltd has 6,264 employees and, after today’s trading, reached a market cap of $12.45 billion. The stock’s P/E Ratio is 11.8. Its P/S ratio is 3.1, P/B ratio is 1.54, and P/FCF ratio is 95.1.

For a complete fundamental analysis analysis of Invesco Ltd, check out’s Stock Valuation Analysis report for IVZ. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The S&P 500 represents the industry standard for large-cap indices. While the Dow Jones Industrial Average (DJIA) may be the most visible stock market index in the country, the S&P 500 has long been relied on by industry insiders and fund managers as the more reliable gauge of portfolio performance.

While the DJIA is price-weighted and only includes 30 stocks, the S&P 500 uses a weighting system that factors in market cap and the size of a company’s free float while including some 500 stocks for a more comprehensive look at the broader markets’ performance. Its performance is far more representative of the large- and mega-cap stocks for any period of time.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:



Symbol Last Price Change % Change










Q BioMed CEO provides a Corporate Update

Denis Corin, CEO of Q BioMed Inc. ”Q“, a biomedical acceleration and development company, focused on licensing and acquiring undervalued biomedical assets in the healthcare sector, provides a corporate update.

Emerging Growth

GTX Corp

GTX Corp, along with its subsidiaries, is engaged in design, development, manufacturing, distribution and sales of products and services in the GPS and BLE wearable technology personal location and wandering…